SynthesisBMC nephrology2024

Safety and efficacy of sparsentan versus irbesartan in focal segmental glomerulosclerosis and IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials.

Ahmed A Abo Elnaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.